Get the Stockscreener App
0.9801
5.77%
-0.0599
Gri Bio Inc stock is traded at $0.9801, with a volume of 957.26K.
It is down -5.77% in the last 24 hours and up +173.74% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$1.04
Open:
$1.03
24h Volume:
957.26K
Relative Volume:
0.23
Market Cap:
$3.49M
Revenue:
-
Net Income/Loss:
$-13.28M
P/E Ratio:
-0.2135
EPS:
-4.5911
Net Cash Flow:
$-8.99M
1W Performance:
+59.58%
1M Performance:
+173.74%
6M Performance:
-81.61%
1Y Performance:
-99.11%
1-Day Range:
$0.9104
$1.03
1-Week Range:
$0.6301
$1.35
52-Week Range:
$0.3015
$134.68
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Gri Bio Inc Stock (GRI) Latest News
Curis (CRIS) Stock Plummets Over 5% Amid Lack of Institutional R - GuruFocus.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
GRI Bio secures funding to advance IPF treatment into 2025 - Investing.com India
GRI Bio secures funding to advance IPF treatment into 2025 By Investing.com - Investing.com UK
GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024 - GlobeNewswire
Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
GRI Bio Announces Exercise of Warrants - GlobeNewswire
Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com
Top Innovation Stocks Surge: PRSO, SYTA, SAVE, ISPC, GRI, BIVIMust-Watch Stocks This Week - openPR
Energy storage ‘key’ to sustainability – report - Yahoo! Voices
As iPhone Sales Soar in China, Is It Time to Buy Apple Stock? - Yahoo! Voices
2 Artificial Intelligence (AI) Stocks That Are No-Brainer Buys - Yahoo! Voices
Statkraft seeks approval for 2.1GW offshore wind farm in Baltic Sea - Yahoo! Voices
BioPorto A/S Announces Changes to the US Commercial Organization - Yahoo Finance
CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement - Yahoo Finance
Health Canada approves Arcutis’ ZORYVE foam for seborrheic dermatitis - Yahoo! Voices
Amcor reports 9% drop in greenhouse gas emissions in 2024 - Yahoo! Voices
Esso Australia completes Kipper Compression Project - Yahoo! Voices
Final countdown: 7 days until TechCrunch Disrupt 2024 kicks off - Yahoo! Voices
Cigna and Humana re-engage in merger talks - Yahoo! Voices
Starr Insurance to operate in Seoul, South Korea - Yahoo! Voices
Alliance Group gets insurance intermediary licence in Germany - Yahoo! Voices
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Live Oak Ventures Participates in Financing of Synply, Inc. - Yahoo Finance
US Stocks Edge Lower; Dow Falls 50 Points - Benzinga
T-Mobile partnership has this beaten down stock launching 🚀 - RagingBull
2 Artificial Intelligence (AI) Stocks That Could Make You a Millionaire - Yahoo! Voices
Are Medical Stocks Lagging BioLife Solutions (BLFS) This Year? - Yahoo Finance
Company News for Oct 21, 2024 - Yahoo Finance
Stock market today: Nasdaq leads stocks lower in wait for earnings to rush in, 10-yr yield climbs to July high - Yahoo
Harris raises more than $220 million in September, outraising Trump 3-to-1 - Yahoo! Voices
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Summit USA 2024 - Yahoo Finance
3 Artificial Intelligence Stocks No One Is Talking About but They Should Be - Yahoo! Voices
JOB ALERT: Goodwill Industries of East Texas needs a supervisor in their south Tyler store - Yahoo News
Is Microsoft Going to $505? 1 Wall Street Analyst Thinks So - Yahoo! Voices
Netflix's Third-Quarter Results Exceeded Expectations. But Is the Stock a Buy? - Yahoo! Voices
Edesa Biotech Announces Upcoming Conference Schedule - Yahoo Finance
This Was the Average Social Security Benefit in 1984, and Here's What It Is Now - Yahoo! Voices
Dynex Capital, Inc. Declares Common Stock Dividends - Yahoo Finance
Fuzzy’s Taco Shop announces new leadership roles - Yahoo! Voices
Saudi Aramco head Amin Nasser positive on China’s continuing oil demand - Yahoo! Voices
FibroBiologics and Charles River link for chronic disease therapies manufacture - Yahoo News
Petrobras to supply Vale with diesel containing renewable content - Yahoo! Voices
SB Energy’s Orion Solar Belt begins commercial operations in US - Yahoo! Voices
FDA clamps partial hold on Phase III trial of BioNTech & OncoC4’s NSCLC therapy - Yahoo! Voices
JDE Peet’s hires ex-Kraft Heinz exec to lead coffee group - Yahoo! Voices
Target Australia ends $2.8m software licensing agreement with daVinci - Yahoo! Voices
Archroma unveils ‘industry-first’ bio-based textile printing system - Yahoo Finance
Save up to $50 With These Gift Card Deals From Costco - Yahoo! Voices
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):